cor 149
Pill imprint cor 149 has been identified as Potassium citrate 10 MEQ.
Potassium citrate is used in the treatment of nephrolithiasis; renal tubular acidosis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy.
Potassium citrate 10 MEQ is not subject to the Controlled Substances Act.
See also related documents.
Potassium citrate Images
- Imprint:
-
cor 149
- Strength:
- 10 MEQ
- Color:
- Yellow
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- carnauba wax
magnesium stearate
stearic acid
- Drug Class:
- Urinary pH modifiers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Rising Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 64980-0138
More POTASSIUM CITRATE resources
- Potassium
- Potassium Citrate (Wolters Kluwer)
- potassium citrate (Cerner Multum)
- Urocit-K 10 Oral (Micromedex) - Includes Dosage Information
- Urocit-K 15 Oral (Micromedex) - Includes Dosage Information
- Urocit-K 5 Oral (Micromedex) - Includes Dosage Information
- potassium citrate (Micromedex) - Includes Dosage Information
- Potassium Citrate (FDA)


